Evidence map›Paper›PMID 39943668›Full record

ArticleWound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society

Comparison of dermal and eschar fibroblasts in full skin equivalents.

Gizem Coşar Kutluoğlu, Marcel Vlig, Anouk Elgersma, Bouke K H L Boekema, Willeke F Daamen, Claudia Doberenz, Dominique Manikowski

Abstract readComparative Study
In one paragraph

Article in Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Comparison of dermal and eschar fibroblasts in full skin equivalents.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gizem Coşar KutluoğluInnovation, Development and Regulatory Affairs, MedSkin Solutions Dr. Suwelack, Billerbeck, Germany.ORCID 0000-0002-0869-7602
Marcel VligBurn Research Lab, Alliance of Dutch Burn Care (ADBC), Beverwijk, The Netherlands.
Anouk ElgersmaBurn Research Lab, Alliance of Dutch Burn Care (ADBC), Beverwijk, The Netherlands.
Bouke K H L BoekemaBurn Research Lab, Alliance of Dutch Burn Care (ADBC), Beverwijk, The Netherlands.ORCID 0000-0002-9085-6982
Willeke F DaamenDepartment of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
Claudia DoberenzInnovation, Development and Regulatory Affairs, MedSkin Solutions Dr. Suwelack, Billerbeck, Germany.
Dominique ManikowskiInnovation, Development and Regulatory Affairs, MedSkin Solutions Dr. Suwelack, Billerbeck, Germany.

Funding

H2020 Marie Skłodowska-Curie Actions 955722
6 · The paper itself

Abstract

Full-thickness burn wounds pose significant problems, demanding specialised therapies to avoid complications and promote recovery. Eschar tissue, which forms in response to severe burns, contains viable fibroblasts, which migrate from the surrounding tissue in response to burn injury and exhibit a myofibroblast phenotype. The goal of this study was to characterise eschar-derived fibroblasts and examine their use for engineered in vitro full skin equivalents in comparison to normal dermal fibroblasts, which were harvested from non-injured skin. Microarray analysis indicated that eschar fibroblasts differ from dermal fibroblasts in various biological processes including inflammation, extracellular matrix formation, cell migration and differentiation. Skin equivalents with eschar fibroblasts showed similarities to those generated using normal dermal fibroblasts in terms of epidermis and dermis formation. However, in contrast to dermal fibroblast-based full skin equivalents, eschar fibroblast-based equivalents exhibited macroscopic contractile behaviour. In addition, eschar fibroblasts-based equivalents demonstrated higher alpha-smooth muscle actin expression on mRNA and protein levels. In conclusion, our findings suggest that eschar fibroblasts-based full skin equivalents hold promise as a platform to study burn wound environments as eschar fibroblasts are clinically more relevant fibroblasts and able to mimic certain aspects of the challenging wound environment in vitro.

Indexed as

BurnsDermisFibroblastsSkinSkin, ArtificialTissue EngineeringWound HealingActinsCell DifferentiationCell MovementCells, CulturedExtracellular MatrixHumansMyofibroblastsActinsburncontractionprimary human cellsskin modelswound healing

Identifiers

PMID39943668
PMCPMC11822215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.